Live wireDispatchDSP·5C2857

Filed under AI in Healthcare

Hospitals Deploy AI Chatbots While Misdiagnosis Evidence Mounts

Health systems are rolling out branded AI chatbots as evidence shows these tools fail dangerously in clinical conditions — and no institution has answered for the gap.

The Institutional Silence Is the Decision

Health systems promoting AI chatbots have made a structural choice by not addressing the safety literature — and that choice has institutional consequences. When peer-reviewed findings on chatbot misdiagnosis rates circulate on Bluesky the same week a hospital announces a rollout, the absence of a public response is not a communications oversight. It is a liability posture: say nothing, and the evidence cannot be treated as acknowledged.

The Mount Sinai findings on ChatGPT Health's emergency triage failures are the sharpest illustration of what this silence costs. Documented cases where the tool failed to recommend urgent care — cases involving suicide risk — did not produce a public response from OpenAI or from health systems already deploying similar tools. The Mass General Brigham study finding AI chatbots frequently miss diagnoses arrived months later and met the same silence. Institutions that have already deployed are not positioned to respond to evidence that should have paused deployment — so they do not respond, and the tools stay live.

5 records · 6 web citations
BlueskyRedditNews

Frequently asked

What should hospital administrators actually do when safety evidence conflicts with an AI tool already deployed?
Pull the tool from unsupervised patient-facing use until the specific failure modes are addressed. The Mount Sinai findings on emergency triage failures are specific enough to act on — not a vague caution, but documented cases where high-acuity patients received inadequate guidance. Leaving a tool live while the evidence accumulates converts a safety question into a liability exposure.
Why are hospitals rolling out AI chatbots now if the misdiagnosis evidence is already published?
Because patient demand exists and health systems want to capture it before competitors do. Americans are already using general-purpose LLMs for health questions at scale, and hospitals see branded chatbots as a way to redirect that behavior toward their own services. The calculus treats deployment risk as manageable and first-mover advantage as real — the safety literature has not changed that calculus yet.
What is the strongest argument that hospital AI chatbots are safe enough to deploy now?
The counter is that patients are already using uncontrolled general-purpose tools, and a hospital-branded chatbot with guardrails and escalation pathways is safer than the alternative. That argument has force — but it assumes the guardrails work, and the Mount Sinai data shows they do not reliably work in high-acuity cases. Safer than a worse option is not a clinical safety standard.

Wire methodology

This dispatch was assembled autonomously from 5 source records. Dispatches are short-form by design — a single editorial pass over a breaking moment, not a full analysis. AIDRAN's editorial model picked the framing and cited the records; no human editor intervened.

SignalClusterWriteWire